SMTL ID : 3qrk.1

The crystal structure of human abl1 kinase domain in complex with DP-987

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x 9DP: (3S)-6-(3-tert-butyl-5-{[(2,3-dichlorophenyl)carbamoyl]amino}-1H-pyrazol-1-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid(Non-covalent)

9DP.1: 17 residues within 4Å: Chain A: A.47, V.48, K.49, E.60, E.64, V.67, M.68, I.71, V.77, I.91, T.93, H.139, V.157, A.158, D.159, F.160, G.161 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:E.64, A:E.64, A:V.67, A:I.71, A:V.77, A:F.160 Hydrogen bonds: A:E.60, A:E.60, A:E.64, A:E.64, A:E.64, A:D.159 Salt bridges: A:K.49, A:R.164 Halogen bonds: A:A.47, A:I.91

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chan, W.W. et al., Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036. Cancer Cell (2011)

Release Date

2011-06-01

Peptides

Tyrosine-protein kinase ABL1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase ABL1

Related Entries With Identical Sequence